With studies planned for kids as young as 6 years old, this development follows the path paved by other GLP-1 medications like semaglutide (Wegovy), which have already shown significant promise in helping teens manage their weight
FRIDAY, May 31, 2024 (HealthDay News) -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from cardiovascular causes, according to a study published online May 24 in the New England Journal of Medicine to coincide with the annual European Renal Association Congress, held from May 23 to 26 in Stockholm
By temporarily reducing the biological drive to overeat, patients can more successfully implement the nutrition and exercise strategies that lead to lasting change
J Thorac Oncol 9(8):1202-6, 2014
1015% of adults use antidepressants, the majority of which are SSRIs
This is a non-negotiable compliance marker